| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
AP521 manufacturers
- AP521
-
- $1520.00
-
2026-07-16
- CAS:151227-08-6
- Purity:
- Supply Ability: 10g
- AP521
-
- $1520.00
-
2026-07-15
- CAS:151227-08-6
- Purity:
- Supply Ability: 10g
- AP521
-
- $1520.00
-
2025-08-22
- CAS:151227-08-6
- Purity:
- Supply Ability: 10g
|
| Product Name: | AP521 | | Synonyms: | AP521;AP521,AP-521;N-(1,3-Benzodioxol-5-ylmethyl)-1,2,3,4-tetrahydro-[1]benzothiolo[2,3-c]pyridine-3-carboxamide hydrochloride | | CAS: | 151227-08-6 | | MF: | C20H19ClN2O3S | | MW: | 402.89 | | EINECS: | | | Product Categories: | | | Mol File: | 151227-08-6.mol |  |
| | AP521 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | color | White to off-white |
| | AP521 Usage And Synthesis |
| Uses | AP521 is an agonist of human 5-HT1A receptor with an IC50 of 94 nM. | | in vivo | AP521 significantly increases the number of shock acceptances [F(5,105)=4.46, P<0.01] at doses between 0.5 to 10 mg/kg. Oral administration of AP521 at 3 and 10 mg/kg significantly decreases freezing time [F(3,60)=2.89, P<0.05]. AP521 significantly increases the time spent on the open arms by approximately 2-fold as compare to the vehicle treated group [F(3, 36)=4.21, P<0.05 for AP521]. The anxiolytic-like effect of AP521 appears to be dose-related. AP521 significantly increases the extracellular 5-HT level of the medial prefrontal cortex (mPFC) at 10 mg/kg from 0.5 to 1 h after administration. AP521 at 3 mg/kg tends to increase the extracellular 5-HT level, however, this increase is not significant[1]. | | IC 50 | 5-HT1A Receptor: 94 nM (IC50, in human); 5-HT1A Receptor: 135 nM (IC50, in rat); 5-HT1B Receptor: 254 nM (IC50, in rat); 5-HT1B Receptor: 5530 nM (IC50, in human); 5-HT1D Receptor: 418 nM (IC50, in human); 5-HT5A Receptor: 422 nM (IC50, in human); 5-HT7 Receptor: 198 nM (IC50, in rat) | | References | [1] Kasahara K, et al. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats. J Pharmacol Sci. 2015 Jan;127(1):109-16. DOI:10.1016/j.jphs.2014.11.008 |
| | AP521 Preparation Products And Raw materials |
|